The significance of tumour markers as an indication for mediastinoscopy in non-small cell lung cancer

Respirology

Volumn 8, Issue 2, 2003, Pages 163-167

  Ando, Soichiro ^a,b   Kimura, Hideki ^a   Iwai, Naomichi ^a   Kakizawa, Kimitaka ^a   Shima, Masayuki ^a   Ando, Michiko ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA CANCER CENTER   (Japan)

Author keywords

Mediastinoscopy; Non small cell lung cancer; Tumour markers

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; NEURON SPECIFIC ENOLASE; PROGASTRIN RELEASING PEPTIDE; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL FEATURE; DIAGNOSTIC TEST; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINOSCOPY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; THORACOTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 0038610738     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00443.x     Document Type: Article

References (21)

1. Kirschner PA. Lung cancer; preoperative radiation therapy and surgery. NY State J. Med. 1981; 81: 339-42.
2. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg. Clin. North Am. 1987; 67: 1037-49.
3. Watanabe Y, Shimizu J, Oda M et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann. Thorac. Surg. 1991; 51: 253-61.
4. Pearson FG, DeLarue NC, Ilves R, Todd TR, Cooper JD. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J. Thorac. Cardiovasc. Surg. 1982; 83: 1-11.
5. Rusch VW, Albain KS, Crowley JJ et al. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial. J. Thorac. Cardiovasc. Surg. 1993; 105: 97-104.
6. Van Schil PEY, Van Hee RHGG, Schoofs ELG. The value of mediastinoscopy in preoperative staging of bronchogenic carcinoma. J. Thorac. Cardiovasc. Surg. 1989; 97: 240-4.
7. Hammoud ZT, Anderson RC, Meyers BF et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J. Thorac. Cardiovasc. Surg. 1999; 118: 894-9.
8. Aronchick JM. CT of mediastinal lymph nodes in patients with non-small cell lung carcinoma. Radiol. Clin. North Am. 1990; 28: 573-81.
9. Rendina EA, Bognolo DA, Mineo TC et al. Computed tomography for the evaluation of intrathoracic invasion by lung cancer. J. Thorac. Cardiovasc. Surg. 1987; 94: 57-63.
10. Brion JP, Depauw L, Kuhn G, de Fracquen P, Friberg J, Rocmans Struyven J. Role of computed tomography and mediastinoscopy in preoperative staging of lung carcinoma. J. Comput. Assist. Tomogr. 1985; 9: 480-4.
11. Patterson GA, Ginsberg RJ, Poon PY et al. A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma. J. Thorac. Cardiovasc. Surg. 1987; 94: 679-84.
12. Daly BD Jr, Faling LJ, Bite G et al. Mediastinal lymph node evaluation by computed tomography in lung cancer. An analysis of 345 patients grouped by TNM staging, tumor size, and tumor location. J. Thorac. Cardiovasc. Surg. 1987; 94: 664-72.
13. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and the European Respiratory Society. Am. J. Respir. Crit. Care Med. 1997; 156: 320-32.
14. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J. Thorac. Cardiovasc. Surg. 1999; 117: 593-8.
15. Takamochi K, Nagai K, Suzuki K, Yoshida J, Ohde Y, Nishiwaki Y. Clinical predictors of N2 disease in non-small cell lung cancer. Chest 2000; 117: 1577-82.
16. Union Internationale Contre le Cancer. TNM Classification of Malignant Tumours. Wiley-Liss Inc, New York, 1997.
17. Dillemans B, Deneffe G, Verschakelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 1994; 8: 37-42.
18. Daly BDT, Mueller JD, Faling LJ et al. N2 lung cancer: outcome in patients with false-negative computed tomographic scans of the chest. J. Thorac. Cardiovasc. Surg. 1993; 105: 904-11.
19. Daniels JMA, Rijna H, Postmus PE, van Mourik JC. Mediastinoscopy as a standardised procedure for mediastinal lymph node staging in non-small cell lung carcinoma. Eur. J. Cardiothorac. Surg. 2001; 19: 377-8.
20. Margaritora S, Cesario A, Galetta D, Granone P. Mediastinoscopy as a standardised procedure for mediastinal lymph node staging in non-small cell carcinoma. Do we have to accept the compromise? Eur. J. Cardiothorac. Surg. 2001; 20: 652-4.
21. Ando S, Kimura H, Iwai N et al. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Anticancer Res. 2001; 21: 3085-92.